Preoperative chemoembolization of hepatocellular carcinoma. A comparative study

Archives of Surgery

Volumn 133, Issue 7, 1998, Pages 767-772

  Paye, François ^a   Jagot, Pascal ^a   Vilgrain, Valérie ^a   Farges, Olivier ^a   Borie, Dominique ^a   Belghiti, Jacques ^a  

^a BEAUJON HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; AMOXICILLIN PLUS CLAVULANIC ACID; CIMETIDINE; DOXORUBICIN; GELATIN SPONGE; IODINATED POPPYSEED OIL;

ABDOMINAL PAIN; ADULT; ARTICLE; ARTIFICIAL EMBOLISM; CANCER RECURRENCE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HISTOPATHOLOGY; HUMAN; LIVER CELL CARCINOMA; LIVER RESECTION; MALE; PERMEABILITY; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SURVIVAL RATE; TREATMENT OUTCOME; TUMOR NECROSIS; TUMOR VOLUME;

CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; CHEMOEMBOLIZATION, THERAPEUTIC; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PREOPERATIVE CARE;

EID: 0031901806     PISSN: 00040010     EISSN: None     Source Type: Journal    
DOI: 10.1001/archsurg.133.7.767     Document Type: Article

References (40)

1. Al-Hadeedi S, Choi TK, Wong J. Extended hepatectomy for hepatocellular carcinoma. Br J Surg. 1990;77:1247-1250.
2. Franco D, Capussotti L, Smadja C. Resection of hepatocellular carcinomas: results in 72 European patients with cirrhosis. Gastroenterology. 1990;98:733-738.
3. Belghiti J. Resection of hepatocellular carcinoma complicating cirrhosis. Br J Surg. 1991;78:257-258.
4. Iwatsuki S, Starzl TE, Sheahan DG. Hepatic resection versus transplantation for hepatocellular carcinoma. Ann Surg. 1991;214:221-229.
5. Yoshimi F, Nagao T, Inoue S, et al. Comparison of hepatectomy and transcatheter arterial chemoembolization for the treatment of hepatocellular carcinoma: necessity for prospective randomized trial. Hepatology. 1992;16:702-706.
6. Nagasue N, Uchida M, Makino Y, et al. Incidence and factors associated with intrahepatic recurrence following resection of hepatocellular carcinoma. Gastroenterology. 1993;105:488-494.
7. Nonami T, Isshiki K, Kishimoto W, Harada A, Nakao A, Tagaki H. The potential role of postoperative hepatic artery chemotherapy in patients with high-risk hepatomas. Ann Surg. 1990;213:222-226.
8. Belghiti J, Panis Y, Farges O, Benhamou JP, Fekete F. Intrahepatic recurrence after resection of hepatocellular carcinoma complicating cirrhosis. Ann Surg. 1991; 214:114-117.
9. Takayashu K, Wakao F, Moriyama N, et al. Postresection recurrence of hepatocellular carcinoma treated by arterial embolization: analysis of prognostic factors. Hepatology. 1992;16:906-911.
10. Taniguchi K. Nakata K, Kato Y, et al. Treatment of hepatocellular carcinoma with transcatheter arterial embolization. Cancer. 1994;73:1341-1345.
11. Jeng KS, Yang FS, Chiang HJ, Ohta I. Repeat operation for nodular recurrent hepatocellular carcinoma within the cirrhotic liver remnant: a comparison with transcatheter arterial chemoembolization. World J Surg. 1992;16:1188-1192.
12. Kanematsu T, Matsumata T, Shirabe K, et al. A comparative study of hepatic resection and transcatheter arterial embolization for the treatment of primary hepatocellular carcinoma. Cancer. 1993;71:2181-2186.
13. Hwang TS, Chen MF, Lee TY, Chen TJ, Lin DY, Liaw YF. Resection of hepatocellular carcinoma after transcatheter arterial embolization: reevaluation of the advantages and disadvantages of preoperative embolization. Arch Surg. 1987; 122:756-759.
14. Shimamura Y, Gunvén P, Takenaka Y, et al. Combined peripheral and central chemoembolization of liver tumors. Cancer. 1988;61:238-242.
15. Bismuth H. Morino M, Sherlock D, et al. Primary treatment of hepatocellular carcinoma by arterial chemoembolization. Am J Surg. 1992;163:387-394.
16. Higushi T, Kikushi M, Okazaki M. Hepatocellular carcinoma after transcatheter hepatic arterial embolization. Cancer. 1993;73:2259-2267.
17. Wu C, Ho Y, Ho W, Liu T, P'eng F. Preoperative transcatheter arterial chemoembolization for resectable large hepatocellular carcinoma: a reappraisal. Br J Surg. 1995;82:122-126.
18. Nagasue N, Galizia G, Kohno H. et al. Adverse effects of preoperative chemoembolization for resectable hepatocellular carcinoma: a retrospective comparison of 138 liver resections. Surgery. 1989;106:81-86.
19. Imaoka S, Sasaki Y, Shibata T, et al. A preoperative chemoembolization therapy using lipiodol cisplatin and gelatin sponge for hepatocellular carcinoma. Cancer Chemother Pharmacol. 1989;23:S126-S128.
20. Monden M, Okamura J, Sakon M, et al. Significance of transcatheter chemoembolization combined with surgical resection for hepatocellular carcinomas. Cancer Chemother Pharmacol. 1989;23:590-595.
21. Adachi E, Matsumata T, Nishisaki T, Hashimoto H, Tsuneyoshi M, Sugimashi K. Effects of preoperative transcatheter hepatic arterial chemoembolization for hepatocellular carcinoma. Cancer. 1993;72:3593-3598.
22. Harada T, Matsuo K, Inoue T, Tamesue S, lnoue T, Nakamura I. Is preoperative chemoembolization safe and effective for hepatocellular carcinoma? Ann Surg. 1996;224:4-9.
23. Nagao T, Inoue S, Yoshimi F, et al. Postoperative recurrence of hepatocellular carcinoma. Ann Surg. 1990;211:28-33.
24. Okuda K, Ohtsuhi T, Obata H, et al. Natural history of hepatocellular carcinoma and prognosis in relation to treatment: study of 850 patients. Cancer. 1985;56: 918-928.
25. Jwo SC, Chiu JH, Chau GY, Loong CC, Lui WY. Risk factors linked to tumor recurrence of human hepatocellular carcinoma after hepatic resection. Hepatology. 1992;16:1367-1371.
26. Belghiti J. Resection hépatique chez le cirrhotique. In: Belghiti J, Gillet M, eds. La Chirurgie Digestive chez le Cirrhotique: Rapport du 93éme Congrès Français de Chirurgie. Paris, France: Springer-Verlag; 1993:113-129.
27. Yu YQ, Xu DB, Zhou XD, Lu JZ, Tang ZY, Mack P. Experience with liver resection after hepatic arterial chemoembolization for hepatocellular carcinoma. Cancer. 1993;71:62-65.
28. Imaoka S, Sasaki Y, Matsutani S, et al. Necrosis of hepatocellular carcinoma caused by spontaneously arising arterial thrombus. Hepatogastroenterology. 1994;41: 359-362.
29. Liou TC, Shih SC, Kao CR, Chou SY, Lin SC, Wang HY. Pulmonary metastasis of hepatocellular carcinoma associated with transarterial chemoembolization. J Hepatology. 1995;23:563-568.
30. Ng IO, Lai EC, Ng MM, Fan ST. Tumor encapsulation in hepatocellular carcinoma: a pathologic study of 189 cases. Cancer. 1992;70:45-49.
31. Yoshida Y, Kanematsu T, Matsumata T, Takenaka K, Sugimashi K. Surgical margin and recurrence after resection of hepatocellular carcinoma in patients with cirrhosis. Ann Surg. 1989;209:297-301.
32. Matsumata T, Kanematsu T, Takenaka K, Sugimashi K. Lack of intra-hepatic recurrence of hepatocellular carcinoma by temporary portal venous embolisation with starch microspheres. Surgery. 1989;105:188-191.
33. Groupe d'Etude et de Traitement du Carcinome Hépatocellulaire. A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma. N Engl J Med. 1995;332:1256-1261.
34. Chung JW, Park JH, Han JK, et al. Hepatic tumors: predisposing factors for complications of transcatheter oily chemoembolization. Radiology. 1996;198:33-40.
35. Castells A, Bruix J, Ayuso C, et al. Transarterial embolization for hepatocellular carcinoma: antibiotic prophylaxis and clinical meaning of post-embolization fever. J Hepatol. 1995;22:410-415.
36. Uchida M, Kohno H, Kubota H, et al. Role of preoperative transcatheter arterial oily chemoembolization for resectable hepatocellular carcinoma. World J Surg. 1996;20:326-331.
37. Portolani N, Tiberio AM, Bonardelli S, et al. Arterial chemoembolization in hepatocellular carcinoma suitable for surgery. Hepatogastroenterology. 1996;43: 1566-1574.
38. Pilchmayr R, Weinmann A, Steinhoff G, Ringe B. Liver transplantation for hepatocellular carcinoma: clinical results and future aspects. Cancer Chemother Pharmacol. 1992;31:S157-S161.
39. Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med. 1996; 334:693-699.
40. Sitzmann JV, Abrams R. Improved survival for hepatocellular cancer with combination surgery and multimodality treatment. Ann Surg. 1993;217:149-154.